Coegin Pharma AB (NGM:COEGIN)

Coegin Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.68	5.55	3.82	25.66	16.65
Cash & Short-Term Investments	19.68	5.55	3.82	25.66	16.65
Cash Growth	254.70%	45.39%	-85.13%	54.12%	-
Other Receivables	0.99	0.64	3.13	4.64	2.5
Receivables	0.99	0.64	3.13	4.64	2.5
Prepaid Expenses	0.17	0.02	0.02	0.03	-
Other Current Assets	-0	-	-	-	-
Total Current Assets	20.84	6.21	6.97	30.33	19.14
Property, Plant & Equipment	0.15	0.3	0.49	0	0
Other Intangible Assets	6.05	8.92	11.79	-	-
Other Long-Term Assets	-	-	10	-	-
Total Assets	27.04	15.43	29.25	30.34	19.15
Accounts Payable	0.98	1.79	2	9.73	1.77
Accrued Expenses	0.66	2.66	1.71	0.22	-
Current Income Taxes Payable	-	-	0.18	-	-
Other Current Liabilities	0.15	4.24	4.34	0.31	0.66
Total Current Liabilities	1.78	8.68	8.23	10.26	2.43
Total Liabilities	1.78	8.68	8.23	10.26	2.43
Common Stock	12.44	4.7	35.33	27.57	23.11
Additional Paid-In Capital	136.2	101.6	94.76	66.38	41.5
Retained Earnings	-	-	-	-75.07	-47.93
Comprehensive Income & Other	-123.38	-99.54	-109.08	1.2	0.04
Shareholders' Equity	25.26	6.75	21.01	20.07	16.71
Total Liabilities & Equity	27.04	15.43	29.25	30.34	19.15
Net Cash (Debt)	19.68	5.55	3.82	25.66	16.65
Net Cash Growth	254.70%	45.39%	-85.13%	54.12%	-
Net Cash Per Share	1.04	0.60	0.56	4.32	12.74
Filing Date Shares Outstanding	24.88	9.39	6.94	6.94	1.31
Total Common Shares Outstanding	24.88	9.39	6.94	6.94	1.31
Working Capital	19.06	-2.47	-1.26	20.07	16.71
Book Value Per Share	1.02	0.72	3.03	2.89	12.79
Tangible Book Value	19.21	-2.17	9.22	20.07	16.71
Tangible Book Value Per Share	0.77	-0.23	1.33	2.89	12.79
Machinery	-	0.64	0.68	0.15	0.15

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.